Document Detail

Three most common nonsynonymous UGT1A6*2 polymorphisms (Thr181Ala, Arg184Serand Ser7Ala) and therapeutic response to deferiprone in β-Thalassemia Major patients.
MedLine Citation:
PMID:  24036429     Owner:  NLM     Status:  Publisher    
Deferiprone is used as a chelation agent in chronic iron overload in β-thalassemia patients. Patients on deferiprone therapy show variable response to this drug in terms of reduction in iron overload as well as adverse drug reactions (ADRs). The pharmacogenetic studies on deferiprone have not carried out in patients with blood disorders in India. Therefore, the present study was carried out to evaluate the three most common nonsynonymous UGT1A6 polymorphisms Thr181Ala (541 A/G), Arg184Ser (552 A/C) and Ser7Ala (19T/G) and therapeutic response to deferiprone in β-thalassemia major patients. Two hundred and eighty six (286) β-thalassemia major patients were involved in the study. Serum ferritin levels were estimated periodically to assess the status of the iron overload and the patients were grouped into responders and non-responders depending on the ferritin levels. The UGT1A6*2 polymorphisms were detected by PCR-RFLP methods. The association between the genotypes and outcome as well as ADRs was evaluated by Open EPI software. A significant difference was observed in the genotypic distribution of UGT1A6*2 Thr181Ala polymorphism in responders and non-responders. However, there was no difference in the genotypic distribution between patients with and without ADRs. As far as the UGT1A6*2 Arg184Ser polymorphism is concerned, no significant difference was observed between responders and non-responders. Further, evaluating the association of UGT1A6*2 Ser7Ala polymorphism with drug response, there was no significant difference in the genotypic distribution between responders and non-responders. However, there was a significant difference between responders with and without ADRs and non-responders with and without ADRs. In addition to this haplotype analysis was also carried out. However, we did not find any specific haplotype to be significantly associated with the deferiprone response in β-thalassemia major patients.
Sneha Dadheech; A Venkateswara Rao; Uzma Shaheen; Mohammed Dyia Hussien; Suman Jain; A Jyothy; Anjana Munshi
Related Documents :
24705749 - The physiological uptake pattern of (18)f-fdg in the left ventricular myocardium of pat...
24465659 - Clinical oxidative stress during leprosy multidrug therapy: impact of dapsone oxidation.
24922509 - Microbiota and metabolome associated with immunoglobulin a nephropathy (igan).
23112259 - Low-voltage eeg activity presenting from psychotic stage in a patient with anti-nmda re...
24526499 - The prophylactic placement of hemoclips to prevent delayed post-polypectomy bleeding: a...
22986109 - Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa.
2429019 - Increased heterogeneity of serum thyroglobulin in thyroid cancer patients as determined...
18379549 - Contrasting clinical outcomes between different modes of peritoneal dialysis regimens: ...
3288959 - Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-9-11
Journal Detail:
Title:  Gene     Volume:  -     ISSN:  1879-0038     ISO Abbreviation:  Gene     Publication Date:  2013 Sep 
Date Detail:
Created Date:  2013-9-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7706761     Medline TA:  Gene     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Elsevier B.V. All rights reserved.
Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Begumpet, Hyderabad-500016, India; Dr. NTR University of Health Sciences, Vijayawada, A.P., India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The switch role of the Tmod4 in the regulation of balanced development between myogenesis and adipog...
Next Document:  Identification of Novel Target Genes Involved in Indian Fanconi Anemia Patients using Microarray.